Amy Warner is a co-founder at LIFELINE, where they focus on drug discovery and cancer genomics. With a PhD in Biology from the University of Cambridge, Amy has an extensive background in cancer chemical biology, performing high-throughput screens and optimizing therapeutic modalities. They served as a postdoctoral researcher at Gilead Sciences, collaborating on innovative research projects aimed at improving patient quality of life. Amy has also made contributions in innate immune signaling related to inflammatory diseases.
This person is not in the org chart
This person is not in any teams
This person is not in any offices